Acasti Pharma Inc. (ACST)
NASDAQ: ACST · Real-Time Price · USD
2.780
+0.060 (2.21%)
Sep 19, 2024, 4:00 PM EDT - Market closed
Acasti Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | -11.45 | -12.85 | -42.43 | -9.82 | -19.68 | -25.51 | Upgrade
|
| Depreciation & Amortization | 0.01 | 0.01 | 0.12 | - | 0.92 | 2.32 | Upgrade
|
| Other Amortization | - | - | - | - | 0.26 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.07 | -0.06 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.04 | 0.04 | 33.95 | 0.25 | 5.7 | - | Upgrade
|
| Stock-Based Compensation | 1.07 | 0.91 | 1.81 | 1.34 | 1.17 | 1.95 | Upgrade
|
| Other Operating Activities | -0.93 | 0.9 | -9.55 | -6.22 | 3.24 | 1.51 | Upgrade
|
| Change in Accounts Receivable | 0.44 | 0.08 | -0.3 | -0.02 | 0.06 | 0.58 | Upgrade
|
| Change in Accounts Payable | 0.71 | -1.65 | 0.41 | -2.39 | -6.7 | -3.39 | Upgrade
|
| Change in Other Net Operating Assets | 0.5 | 0.29 | 0.07 | -0.38 | 0.7 | -0.41 | Upgrade
|
| Operating Cash Flow | -9.69 | -12.33 | -15.91 | -17.23 | -14.32 | -22.95 | Upgrade
|
| Capital Expenditures | -0.02 | -0.02 | -0.02 | - | -0.07 | -0.32 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.11 | 0.11 | - | - | - | - | Upgrade
|
| Investment in Securities | - | 0.02 | 13.17 | -3.52 | -9.79 | 8.46 | Upgrade
|
| Investing Cash Flow | 0.09 | 0.1 | 13.15 | -3.52 | -9.86 | 8.14 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -1.56 | Upgrade
|
| Total Debt Repaid | - | - | - | - | - | -1.56 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | - | - | -1.56 | Upgrade
|
| Issuance of Common Stock | 7.36 | 7.36 | 0.3 | - | 59.63 | 14.73 | Upgrade
|
| Other Financing Activities | - | - | - | - | -0.14 | 0.01 | Upgrade
|
| Financing Cash Flow | 7.36 | 7.36 | 0.3 | - | 59.49 | 13.18 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0 | - | -0.01 | 0.15 | 1.39 | -1 | Upgrade
|
| Net Cash Flow | -2.24 | -4.87 | -2.46 | -20.6 | 36.7 | -2.63 | Upgrade
|
| Free Cash Flow | -9.71 | -12.36 | -15.93 | -17.23 | -14.39 | -23.27 | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | -7340.82% | - | Upgrade
|
| Free Cash Flow Per Share | -0.93 | -1.30 | -2.14 | -2.81 | -5.82 | -13.21 | Upgrade
|
| Levered Free Cash Flow | -5.58 | -7.4 | -9.06 | -4.57 | -7.81 | -18.48 | Upgrade
|
| Unlevered Free Cash Flow | -5.58 | -7.4 | -9.06 | -4.57 | -7.91 | -18.32 | Upgrade
|
| Change in Net Working Capital | -1.66 | 1.26 | -0.4 | -1.68 | 3.25 | 7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.